Literature DB >> 9256033

[A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis].

T Imagawa1, S Katakura, M Mori, Y Aihara, T Mitsuda, S Yokota.   

Abstract

We reported a child of macrophage activation syndrome (MAS) associated with the course of systemic juvenile rheumatoid arthritis (sJRA). The clinical and laboratory findings in our case was ascribed to the overproduced inflammatory cytokines especially TNF-alpha by activated macrophages. Moreover, macrophage-colony stimulating factor (M-CSF) was also elevated in the active phase of the disease, and decreased in the convalescent phase, indicating that M-CSF can be the most potent stimulator of macrophages to produce inflammatory cytokines. Cyclosporine A along with plasmaexchange and corticosteroid, instead of VP16 or other immunosuppresive agents, was effecting in the management of this severe, life-threatening MAS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9256033

Source DB:  PubMed          Journal:  Ryumachi        ISSN: 0300-9157


  2 in total

1.  [Pathogenesis and morphology of hemophagocytic syndrome in the spleen].

Authors:  S Gattenlöhner; H K Müller-Hermelink
Journal:  Pathologe       Date:  2008-03       Impact factor: 0.973

2.  Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.

Authors:  Hua-Song Zeng; Xiao-Yan Xiong; Yan-Dan Wei; Hong-Wei Wang; Xiao-Ping Luo
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.